跳至主要内容
临床试验/NCT06661616
NCT06661616已完成不适用

Cognitive Effects Associated With Hippocampal Neurogenesis Induced by Electroconvulsive Therapy in the Treatment of Depression

Centre Hospitalier St Anne1 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2018年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
87
试验地点
1
主要终点
Correlation between increased hippocampal volume and post-ECT retrograde amnesia

研究概览

简要总结

Electroconvulsive therapy (ECT) is the treatment of choice for drug-resistant depression (30% of patients), or when there is a short-term risk to the patient's life. Despite its robust efficacy and rapid onset of action, its use is limited both by the limited range of treatment available and by the cognitive effects sometimes induced. The present study focuses on the links between the efficacy of ECT, its cognitive effects and the formation of new neurons in the hippocampus (hippocampal neurogenesis) associated with this treatment.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Study population: depressed subjects treated with ECT
  • Male or female over 18 years of age
  • Hospitalised at the Centre Hospitalier Sainte-Anne
  • Suffering from a unipolar or bipolar major depressive episode, according to DSM5 criteria
  • Indication for ECT treatment
  • Patient has given informed written consent
  • Beneficiary of a social security scheme
  • Control population: depressed subjects treated without ECT
  • Male or female over 18 years of age
  • Hospitalised at the Centre Hospitalier Sainte-Anne
  • Suffering from a unipolar or bipolar major depressive episode, according to DSM5 criteria
  • Patient who has given informed written consent
  • Beneficiary of a social security scheme
  • Control population: healthy volunteers
  • Male or female over 18 years of age
  • Patient with written informed consent
  • Beneficiary of a social security scheme

排除标准

  • Study population: depressed subjects with ECT
  • Psychiatric comorbidity: schizophrenia, pervasive developmental disorder, dependence on a substance other than tobacco
  • Neurological comorbidity: Parkinson's disease, dementia
  • ECT treatment in the 6 months prior to inclusion
  • Compulsory care
  • Protected adults, persons under court protection measures
  • Persons deprived of liberty by judicial or administrative decision;
  • Refusal of consent to ECT treatment
  • Contraindications to ECT (HTIC, recent history of stroke, severe uncontrolled arterial hypertension, contraindication to anaesthesia)
  • Contraindications to MRI (patients with metal prostheses, claustrophobia)
  • Pregnant or breast-feeding women
  • Control population: depressed subjects without ECT
  • Psychiatric comorbidity: schizophrenia, pervasive developmental disorder, dependence on any substance other than tobacco
  • Neurological comorbidity: Parkinson's disease, dementia
  • ECT treatment in the 6 months prior to inclusion
  • Compulsory care
  • Protected adults, persons under court protection measures
  • Persons deprived of liberty by judicial or administrative decision;
  • Pregnant or breast-feeding women
  • Control population: healthyvolunteers
  • Protected adults, persons under legal protection,
  • Persons deprived of their liberty by judicial or administrative decision ;
  • persons hospitalised for purposes other than research
  • Clear psychiatric history
  • Dependence on any substance other than tobacco
  • Neurological history: Parkinson's disease, dementia
  • Pregnant or breast-feeding women

结局指标

主要结局

Correlation between increased hippocampal volume and post-ECT retrograde amnesia

时间窗: After a course of ECT, up to 3 months

次要结局

未报告次要终点

研究者

发起方
Centre Hospitalier St Anne
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验